CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-27 | Presnell Sharon Collins Chief Scientific Officer | Grant or award | +200,000 | 299,188 | ||
| 2017-06-27 | KUSSMAN CRAIG Chief Financial Officer | Grant or award | +220,000 | 352,000 | ||
| 2017-06-27 | Gallant Paul General Manager | Grant or award | +160,000 | 202,738 | ||
| 2017-06-27 | David Eric CSO & EVP Pre-Clinical Dev | Grant or award | +190,000 | 890,703 | ||
| 2017-06-27 | Bush Jennifer General Counsel & Secretary | Grant or award | +35,000 | 79,951 | ||
| 2017-06-27 | Bush Jennifer General Counsel & Secretary | Grant or award | +190,000 | 269,951 | ||
| 2017-05-16 | Gallant Paul General Manager | Shares withheld for taxes | −1,317 | $2.86 | $4K | 42,738 |
| 2017-05-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,263 | $2.86 | $4K | 700,703 |
| 2017-05-16 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −1,235 | $2.86 | $4K | 44,951 |
| 2017-05-16 | Presnell Sharon Collins Chief Scientific Officer | Shares withheld for taxes | −1,167 | $2.86 | $3K | 99,188 |
| 2017-04-24 | CROUCH TAYLOR CEO & President | Grant or award · Stock Option (Right to Buy) | +2,088,212 | 2,088,212 | ||
| 2017-02-16 | Presnell Sharon Collins Chief Scientific Officer | Shares withheld for taxes | −1,390 | $2.95 | $4K | 115,355 |
| 2017-02-16 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −5,742 | $2.95 | $17K | 6,038,173 |
| 2017-02-16 | Gallant Paul General Manager | Shares withheld for taxes | −1,320 | $2.95 | $4K | 44,055 |
| 2017-02-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,390 | $2.95 | $4K | 701,966 |
| 2017-02-16 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −1,390 | $2.95 | $4K | 46,186 |
| 2017-02-09 | Murphy Keith Chairman, CEO and President | Sale | −25,000 | $3.68 | $92K | 6,043,915 |
| 2017-02-08 | Murphy Keith Chairman, CEO and President | Option exercise | +30,000 | $1.00 | $30K | 6,068,915 |
| 2017-02-08 | Murphy Keith Chairman, CEO and President | Option exercise · Warrant | −30,000 | 0 | ||
| 2017-01-24 | Murphy Keith Chairman, CEO and President | Sale | −20,100 | $3.50 | $70K | 6,038,915 |
Page 9 of 13 · 259 trades